TRANSTAC
Live / Applied — Third extension granted (statement of use) (as of 25 Nov 2025)
What this means for you
Not registered yet, but its 16 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98225361
- Mark type
- Stylized text
- Filed
- 16 Oct 2023
- Published for opposition
- 23 Apr 2024
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 001 — Chemicals: Active biochemical ingredients being biological molecules for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Biological molecules, namely, biochemical reagents for medical purposes for use in therapeutic preparations
Owner
- Dana-Farber Cancer Institute, Inc., Boston, MA, US
- Dana-Farber Cancer Institute, Inc., Boston, MA, US
Prosecution history
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 3 GRANTED
- 25 Nov 2025 — SOU EXTENSION 3 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Apr 2025 — SOU EXTENSION 2 GRANTED
- 23 Apr 2025 — SOU EXTENSION 2 FILED
- 23 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2024 — SOU EXTENSION 1 GRANTED
- 21 Nov 2024 — SOU EXTENSION 1 FILED
- 21 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION